These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15565959)

  • 1. [G receptor kinases. A family of "natural" receptor blockers].
    Theilade JE; Haunsø S; Sheikh SP
    Ugeskr Laeger; 2004 Nov; 166(45):4026-30. PubMed ID: 15565959
    [No Abstract]   [Full Text] [Related]  

  • 2. What are the consequences of phosphorylation and hyperphosphorylation of ryanodine receptors in normal and failing heart?
    Bridge JH; Savio-Galimberti E
    Circ Res; 2008 May; 102(9):995-7. PubMed ID: 18467636
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased pressure on G protein-coupled receptor kinases.
    Bouvier M
    J Clin Invest; 1997 May; 99(9):2060-1. PubMed ID: 9151775
    [No Abstract]   [Full Text] [Related]  

  • 4. Pathophysiological roles of G-protein-coupled receptor kinases.
    Métayé T; Gibelin H; Perdrisot R; Kraimps JL
    Cell Signal; 2005 Aug; 17(8):917-28. PubMed ID: 15894165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic AMP-mediated signal transduction in heart failure: molecular pathophysiology and therapeutic implications.
    Movsesian MA
    J Investig Med; 1997 Oct; 45(8):432-40. PubMed ID: 9394095
    [No Abstract]   [Full Text] [Related]  

  • 6. [The importance of the myocardial adrenoreceptors and their therapeutic significance].
    Brodde OE
    Klin Anasthesiol Intensivther; 1991; 41():72-80. PubMed ID: 1685756
    [No Abstract]   [Full Text] [Related]  

  • 7. Ca2+-calmodulin-dependent protein kinase phosphorylation of ryanodine receptor may contribute to the beta-adrenergic regulation of myocardial contractility independently of increases in heart rate.
    Mattiazzi A; Vittone L; Mundiña-Weilenmann C
    Circ Res; 2008 Jul; 103(1):e10-1; author reply e12. PubMed ID: 18596257
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intrinsic sympathomimetic activity with beta-receptor blockers. Significance for differential therapy (author's transl)].
    Noack E
    MMW Munch Med Wochenschr; 1982 Apr; 124(15):377-80. PubMed ID: 6123078
    [No Abstract]   [Full Text] [Related]  

  • 9. CaM or cAMP: linking beta-adrenergic stimulation to 'leaky' RyRs.
    Sipido KR
    Circ Res; 2007 Feb; 100(3):296-8. PubMed ID: 17307967
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of myofilament dysfunction by beta-blocker therapy in postinfarct remodeling.
    Duncker DJ; Boontje NM; Merkus D; Versteilen A; Krysiak J; Mearini G; El-Armouche A; de Beer VJ; Lamers JM; Carrier L; Walker LA; Linke WA; Stienen GJ; van der Velden J
    Circ Heart Fail; 2009 May; 2(3):233-42. PubMed ID: 19808345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenergic regulation of cAMP/protein kinase A pathway in corneal epithelium and endothelium.
    Grueb M; Bartz-Schmidt KU; Rohrbach JM
    Ophthalmic Res; 2008 Oct; 40(6):322-8. PubMed ID: 18688175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of Disease: ryanodine receptor defects in heart failure and fatal arrhythmia.
    Yano M; Yamamoto T; Ikeda Y; Matsuzaki M
    Nat Clin Pract Cardiovasc Med; 2006 Jan; 3(1):43-52. PubMed ID: 16391617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Digitalis and coronary heart disease (author's transl)].
    Schüren KP; Kötter V; Schröder R
    Z Kardiol; 1980 May; 69(5):319-28. PubMed ID: 6109408
    [No Abstract]   [Full Text] [Related]  

  • 14. Distinct myocardial effects of beta-blocker therapy in heart failure with normal and reduced left ventricular ejection fraction.
    Hamdani N; Paulus WJ; van Heerebeek L; Borbély A; Boontje NM; Zuidwijk MJ; Bronzwaer JG; Simonides WS; Niessen HW; Stienen GJ; van der Velden J
    Eur Heart J; 2009 Aug; 30(15):1863-72. PubMed ID: 19487234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of protein kinase C alpha improves myocardial beta-adrenergic receptor signaling and ventricular function in a model of myocardial preservation.
    D'Souza KM; Petrashevskaya NN; Merrill WH; Akhter SA
    J Thorac Cardiovasc Surg; 2008 Jan; 135(1):172-9, 179.e1. PubMed ID: 18179937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic adenosine monophosphate in acute myocardial infarction with heart failure: slayer or savior?
    Leineweber K; Böhm M; Heusch G
    Circulation; 2006 Aug; 114(5):365-7. PubMed ID: 16880340
    [No Abstract]   [Full Text] [Related]  

  • 17. The place of beta-blockers in cardiovascular medicine.
    Cruickshank JM
    Cardiologia; 1995 Nov; 40(11):829-43. PubMed ID: 8706060
    [No Abstract]   [Full Text] [Related]  

  • 18. Alpha-adrenergic blockade in treatment of heart failure.
    Taylor SH; Majid PA; Sharma B
    Br Heart J; 1972 Feb; 34(2):204. PubMed ID: 4400055
    [No Abstract]   [Full Text] [Related]  

  • 19. [alpha and beta Blockaders for the management of hypertension].
    Tsukiyama H; Ohtsuka K
    Nihon Rinsho; 1984 Feb; 42(2):416-21. PubMed ID: 6143840
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanisms of regulation of G protein-coupled receptor kinases (GRKs) and cardiovascular disease.
    Penela P; Murga C; Ribas C; Tutor AS; Peregrín S; Mayor F
    Cardiovasc Res; 2006 Jan; 69(1):46-56. PubMed ID: 16288730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.